Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity.

[1]  S. Groshen,et al.  Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. , 2001 .

[2]  Misha Ruth Cohen.  Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditional medicine in hepatitis C virus. , 2001, Clinics in liver disease.

[3]  J. Albrecht,et al.  The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. , 2000, Gastroenterology.

[4]  J. Buffington,et al.  Racial differences in knowledge regarding hepatitis C virus infection. , 2000, JAMA.

[5]  W K Roth,et al.  Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. , 2000, Journal of hepatology.

[6]  P. Kwo.  Treatment of chronic hepatitis C in nonresponders to interferon monotherapy , 2000, Current gastroenterology reports.

[7]  William M. Lee,et al.  Racial differences in responses to therapy with interferon in chronic hepatitis C , 1999, Hepatology.

[8]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[9]  A. Williams,et al.  Demographic determinants of hepatitis C virus seroprevalence among blood donors. , 1996, JAMA.

[10]  M. Shindo,et al.  The virological and histological states of anti‐hepatitis C virus–positive subjects with normal liver biochemical values , 1995, Hepatology.

[11]  K. Shimotohno,et al.  Massive Sero–epidemiological Survey of Hepatitis C Virus: Clustering of Carriers on the Southwest Coast of Tsushima, Japan , 1991, Japanese journal of cancer research : Gann.